Wilson Wai Chun Wong

Title: Innovations of Wilson Wai Chun Wong

Introduction

Wilson Wai Chun Wong is an accomplished inventor based in Brookline, MA (US). He holds a total of four patents, showcasing his contributions to the field of biotechnology and gene expression control. His work has significant implications for medical therapies and drug delivery systems.

Latest Patents

One of his latest patents is focused on the repressible control of gene expression. This technology involves inducible and repressible polypeptides and polypeptide systems. It includes split sequence-specific nucleases and split recombinases linked to drug-inducible or drug-repressible dimerization domains. The polypeptides may also comprise sequestering domains and have their expression controlled by an inducible promoter. Additionally, the patent describes polynucleotides, vectors, cells, and pharmaceutical compositions that utilize these polypeptides or polypeptide systems. Methods for using these systems to modulate the expression of a target polypeptide or to treat subjects in need of cell therapy are also included. Another significant patent involves nanofiber scaffolds, which relate to compositions and methods for the sustained delivery of active agents for treating diseases or disorders.

Career Highlights

Throughout his career, Wilson has worked with notable institutions, including Boston University and The General Hospital Corporation. His innovative research has contributed to advancements in biotechnology and therapeutic applications.

Collaborations

Wilson has collaborated with esteemed colleagues such as Yage Ding and Eric M Bressler, further enhancing the impact of his work in the scientific community.

Conclusion

Wilson Wai Chun Wong's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in gene expression control and drug delivery systems.